FABP4 and obesity due to melanocortin 4 receptor deficiency: Cross-sectional studies have shown that an elevated circulating FABP4 level is associated with obesity, insulin resistance, type 2 diabetes mellitus, hypertension, dyslipidemia, dysregulation of purine metabolism, atherosclerosis and disturbance of the heart, liver and kidney13–19.